Pediatric Acquired Demyelinating Syndrome (ADS)—A Proposed Flowchart for Imaging Diagnosis

Abstract

Pediatric acquired demyelinating syndromes (ADS) consists of a group of neuroinflammatory disorders, which include monophasic acute disseminated encephalomyelitis, multiple sclerosis, aquaporin-4 antibody-associated neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and seronegative ADS. Various advances have been made in understanding their pathology, clinical, and imaging features for providing timely and precise diagnosis to ensure appropriate patient management. Imaging serves as an important tool in not only for diagnosis of demyelination but also helps in distinguishing them. In this case series, the authors have tried to assess distinctive imaging features of these disorders and arrive at an algorithmic approach for the diagnosis of various pediatric demyelinating disorders.

Keywords

MOG antibody disease (MOGAD) - demyelinating diseases - acute disseminated encephalomyelitis (ADEM) - magnetic resonance imaging (MRI) - multiple sclerosis - aquaporin-4 antibody associated neuromyelitis optica spectrum disorder (NMOSD)

Publication History

Article published online:
16 October 2023

• References

• 1 Hacohen Y, Mankad K, Chong WK. et al. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children. Neurology 2017; 89 (03) 269-278
• 2 Server Alonso A, Sakinis T, Pfeiffer HCV, Sandvig I, Barlinn J, Marthinsen PB. Understanding pediatric neuroimmune disorder conflicts: a neuroradiologic approach in the molecular era. Radiographics 2020; 40 (05) 1395-1411
• 3 Baumann M, Bartels F, Finke C, Adamsbaum C, Hacohen Y, Rostásy K. E.U. paediatric MOG consortium. E.U. paediatric MOG consortium consensus: Part 2 - Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol 2020; 29: 14-21
• 4 Fadda G, Armangue T, Hacohen Y, Chitnis T, Banwell B. Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care. Lancet Neurol 2021; 20 (02) 136-149
• 5 Kitley J, Waters P, Woodhall M. et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 2014; 71 (03) 276-283
• 6 Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review - Cellina Michaela, Fetoni Vincenza, Ciocca Matteo, Pirovano Marta, Oliva Giancarlo, 2018 [Internet]. [cited 2023 Mar 4]. Accessed July 9, 2023 at: https://journals.sagepub.com/doi/10.1177/1971400917698856?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
• 7 Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria - The Lancet Neurology [Internet]. [cited 2023 Mar 4]. Accessed July 9, 2023 at: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(17)30470-2/fulltext
• 8 Pujari SS, Kulkarni RV, Nadgir DB. et al. Myelin oligodendrocyte glycoprotein (MOG)-IgG associated demyelinating disease: our experience with this distinct syndrome. Ann Indian Acad Neurol 2021; 24 (01) 69-77
• 9 Z Ghali MG. Tumefactive acute disseminated encephalomyelitis. Neurol India 2020; 68 (01) 35-41
• 10 Tumefactive Demyelination in MOG Ab–Associated Disease. Multiple Sclerosis, and AQP-4-IgG–Positive Neuromyelitis Optica Spectrum Disorder | Neurology [Internet]. [cited 2023 Jun 11]. Accessed July 9, 2023 at: https://n.neurology.org/content/100/13/e1418
• 11 Osborn's Brain - 2nd Edition [Internet]. [cited 2023 Mar 4]. Accessed July 9, 2023 at: https://www.elsevier.com/books/osborns-brain/osborn/978-0-323-47776-5
• 12 Nakayama M, Naganawa S, Ouyang M. et al. A review of clinical and imaging findings in tumefactive demyelination. AJR Am J Roentgenol 2021; 217 (01) 186-197
• 13 Krupp LB, Tardieu M, Amato MP. et al; International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler 2013; 19 (10) 1261-1267
• 14 Dutra BG, da Rocha AJ, Nunes RH, Maia ACM. Neuromyelitis optica spectrum disorders: spectrum of MR imaging findings and their differential diagnosis. Radiographics 2018; 38 (01) 169-193
• 15 International consensus diagnostic criteria for neuromyelitis optica spectrum disorders | Neurology [Internet]. [cited 2023 Mar 4]. Accessed July 9, 2023 at: https://n.neurology.org/content/85/2/177.long
• 16 Waldman A, Ness J, Pohl D. et al. Pediatric multiple sclerosis: clinical features and outcome. Neurology 2016; 87 (9, suppl 2): S74-S81
• 17 Castañeda MRRQ, Espiritu AI, Tan MA. Spectrum of pediatric acquired demyelinating syndromes (PADS) of the central nervous system in a tropical developing country: a 10-year retrospective study. J Clin Neurosci 2022; 104: 74-81
• 18 Wendel EM, Thonke HS, Bertolini A. et al; BIOMARKER Study Group. Temporal dynamics of MOG antibodies in children with acquired demyelinating syndrome. Neurol Neuroimmunol Neuroinflamm 2022; 9 (06) e200035
• 19 Brola W, Steinborn B. Pediatric multiple sclerosis - current status of epidemiology, diagnosis and treatment. Neurol Neurochir Pol 2020; 54 (06) 508-517
• 20 Bruijstens AL, Lechner C, Flet-Berliac L. et al; E.U. paediatric MOG consortium. E.U. paediatric MOG consortium consensus: Part 1 - classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol 2020; 29: 2-13
• 21 Polman CH, Reingold SC, Banwell B. et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69 (02) 292-302